Menu

Markets

Research

News

Learn
Paper trading
AI Chat
WatchlistsPortfoliosAlerts
Sign in

VNDA

Vanda Pharmaceuticals Inc.

Healthcare · USD

Set alert

Price alert · VNDA

All alert types
3.79 USD -0.26 -6.42%
As of Oct 30, 2026 Extended hours 3.81 +0.53%
Bid
3.78 × 1
Ask
3.79 × 1
3.74 Day range 4.11
3.79 52-week range 9.56
YTD
-57.03%
1 year
-12.27%
Open
3.97
Prev close
4.05
Mkt cap
229.18M
Vol
1.79M
Avg vol
1.03M
EPS
-4.63
P/E
0.00
Div yield
0.00%
More statistics
Low
3.74
High
4.11
Forward P/E
23.40
Beta
0.77
Short ratio
4.85
Inst. own
78.42%
Dividend
0.00
Ex-div date
Earnings
Feb 5, 2025
50-d avg
4.85
200-d avg
5.03
1y target
10.43

5D chart

Chart tools
Interval
1m5m15m30m
VNDA five-day price chart3.794.004.214.434.64Oct 26Oct 27Oct 28Oct 29Oct 30

Financial health

Altman Z-Score

-1.83 Distress zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

2 / 9 Weak

Nine pass/fail tests of profitability, leverage and efficiency.

FMP rating

C2 / 5 overall

  • DCF 1
  • Return on Equity 1
  • Return on Assets 1
  • Debt / Equity 3
  • P/E 1
  • P/B 4

Valuation

P/E -2.4×
FY 2016: -38.9×FY 2017: -43.4×FY 2018: 52.3×FY 2019: 7.6×FY 2020: 30.6×FY 2021: 26.1×FY 2022: 67.2×FY 2023: 96.6×FY 2024: -15.0×FY 2025: -2.4×
FY 2016 5y median 26.1× FY 2025
P/S 2.4×
FY 2016: 4.7×FY 2017: 4.1×FY 2018: 6.9×FY 2019: 3.8×FY 2020: 2.9×FY 2021: 3.2×FY 2022: 1.6×FY 2023: 1.3×FY 2024: 1.4×FY 2025: 2.4×
FY 2016 5y median 1.6× FY 2025
P/B 1.6×
FY 2016: 5.3×FY 2017: 5.1×FY 2018: 4.8×FY 2019: 2.1×FY 2020: 1.6×FY 2021: 1.7×FY 2022: 0.8×FY 2023: 0.4×FY 2024: 0.5×FY 2025: 1.6×
FY 2016 5y median 0.8× FY 2025
P/FCF -4.7×
FY 2016: -72.9×FY 2017: -185×FY 2018: 288×FY 2019: 19.4×FY 2020: 14.3×FY 2021: 13.7×FY 2022: 13.3×FY 2023: 19.5×FY 2024: -17.1×FY 2025: -4.7×
FY 2016 5y median 13.3× FY 2025
EV/EBITDA -3.5×
FY 2016: -97.4×FY 2017: -46.2×FY 2018: 51.3×FY 2019: 32.7×FY 2020: 19.3×FY 2021: 18.4×FY 2022: 20.9×FY 2023: 12.4×FY 2024: -12.8×FY 2025: -3.5×
FY 2016 5y median 12.4× FY 2025
EV/Sales 2.1×
FY 2016: 4.5×FY 2017: 3.9×FY 2018: 6.6×FY 2019: 3.7×FY 2020: 2.7×FY 2021: 3.1×FY 2022: 1.2×FY 2023: 0.6×FY 2024: 0.9×FY 2025: 2.1×
FY 2016 5y median 1.2× FY 2025
FCF Yield -21.2%
FY 2016: -1.4%FY 2017: -0.5%FY 2018: 0.3%FY 2019: 5.2%FY 2020: 7.0%FY 2021: 7.3%FY 2022: 7.5%FY 2023: 5.1%FY 2024: -5.8%FY 2025: -21.2%
FY 2016 5y median 5.1% FY 2025

Profitability

Gross Margin 94.0%
FY 2016: 83.1%FY 2017: 89.2%FY 2018: 89.4%FY 2019: 89.2%FY 2020: 90.6%FY 2021: 90.5%FY 2022: 90.5%FY 2023: 92.3%FY 2024: 94.3%FY 2025: 94.0%
FY 2016 5y median 92.3% FY 2025
Operating Margin -70.0%
FY 2016: -12.7%FY 2017: -10.2%FY 2018: 11.3%FY 2019: 10.0%FY 2020: 11.0%FY 2021: 15.7%FY 2022: 2.5%FY 2023: -7.2%FY 2024: -20.5%FY 2025: -70.0%
FY 2016 5y median -7.2% FY 2025
Net Margin -102.0%
FY 2016: -12.3%FY 2017: -9.4%FY 2018: 13.1%FY 2019: 50.9%FY 2020: 9.4%FY 2021: 12.3%FY 2022: 2.5%FY 2023: 1.3%FY 2024: -9.5%FY 2025: -102.0%
FY 2016 5y median 1.3% FY 2025
ROE -67.4%
FY 2016: -13.7%FY 2017: -11.8%FY 2018: 9.2%FY 2019: 28.1%FY 2020: 5.1%FY 2021: 6.6%FY 2022: 1.2%FY 2023: 0.5%FY 2024: -3.5%FY 2025: -67.4%
FY 2016 5y median 0.5% FY 2025
ROIC -43.3%
FY 2016: -11.6%FY 2017: -12.5%FY 2018: 7.7%FY 2019: 5.3%FY 2020: 4.3%FY 2021: 6.3%FY 2022: 0.6%FY 2023: -1.0%FY 2024: -6.0%FY 2025: -43.3%
FY 2016 5y median -1.0% FY 2025
ROA -45.1%
FY 2016: -8.6%FY 2017: -7.6%FY 2018: 7.6%FY 2019: 23.9%FY 2020: 4.4%FY 2021: 5.6%FY 2022: 1.0%FY 2023: 0.4%FY 2024: -2.9%FY 2025: -45.1%
FY 2016 5y median 0.4% FY 2025

Growth (YoY)

Revenue 8.7%
FY 2016: 32.8%FY 2017: 13.1%FY 2018: 17.0%FY 2019: 17.6%FY 2020: 9.2%FY 2021: 8.3%FY 2022: -5.3%FY 2023: -24.3%FY 2024: 3.2%FY 2025: 8.7%
FY 2016 FY 2025
Operating Income -271.8%
FY 2016: 53.8%FY 2017: 9.0%FY 2018: 228.6%FY 2019: 4.9%FY 2020: 19.4%FY 2021: 54.8%FY 2022: -85.0%FY 2023: -320.4%FY 2024: -191.4%FY 2025: -271.8%
FY 2016 FY 2025
EPS (diluted) -1068.8%
FY 2016: 56.4%FY 2017: 14.6%FY 2018: 237.1%FY 2019: 339.6%FY 2020: -80.1%FY 2021: 38.1%FY 2022: -81.0%FY 2023: -60.4%FY 2024: -833.9%FY 2025: -1068.8%
FY 2016 FY 2025
Free Cash Flow -579.8%
FY 2016: -195.8%FY 2017: 61.7%FY 2018: 226.6%FY 2019: 872.9%FY 2020: 11.2%FY 2021: 27.4%FY 2022: -50.8%FY 2023: -60.3%FY 2024: -230.8%FY 2025: -579.8%
FY 2016 FY 2025

Financial Health

Current Ratio 2.4×
FY 2016: 3.5×FY 2017: 2.4×FY 2018: 5.6×FY 2019: 6.0×FY 2020: 6.2×FY 2021: 6.4×FY 2022: 5.7×FY 2023: 4.9×FY 2024: 4.4×FY 2025: 2.4×
FY 2016 5y median 4.9× FY 2025
Quick Ratio 2.4×
FY 2016: 3.4×FY 2017: 2.4×FY 2018: 5.6×FY 2019: 5.9×FY 2020: 6.2×FY 2021: 6.4×FY 2022: 5.7×FY 2023: 4.9×FY 2024: 4.4×FY 2025: 2.4×
FY 2016 5y median 4.9× FY 2025
Debt / Equity 0.0×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2016 5y median 0.0× FY 2025
Net Debt / EBITDA 0.6×
FY 2016: 6.0×FY 2017: 2.4×FY 2018: -2.5×FY 2019: -1.2×FY 2020: -1.4×FY 2021: -0.9×FY 2022: -8.8×FY 2023: -13.5×FY 2024: 6.1×FY 2025: 0.6×
FY 2016 5y median -0.9× FY 2025
Interest Coverage 0.0×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2016 5y median 0.0× FY 2025

Dividends

Dividend Yield 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025

Annual · latest fiscal year ends 2025-12-31